TREATMENT OUTCOMES OF FUNCTIONAL CONSTIPATION USING POLYETHYLENE GLYCOL 3350 REGIMEN IN CHILDREN AGED 6 MONTHS TO 6 YEARS AT VINH CITY GENERAL HOSPITAL

Thị Linh Nguyễn, Thị Việt Hà Nguyễn, Thị Quỳnh Anh Phí, Thị Văn Lê

Main Article Content

Abstract

Constipation is a common gastrointestinal disorder in children, with functional constipation accounting for 90–95% of cases. Aims: To evaluate the efficacy of polyethylene glycol (PEG) 3350 regimen in management of functional constipation in children aged 6 months to 6 years at Vinh City General Hospital. Materials and Methods: A prospective, interventional, uncontrolled study was conducted on 62 children aged 6 months to 6 years who were diagnosed with functional constipation according to Rome IV criteria at Vinh City General Hospital from August 1, 2024, to July 31, 2025. Results: The mean defecation frequency increased significantly from 2.5 ± 1.6 times/week before treatment to 4.0 ± 1.6, 4.9 ± 1.5, and 5.5 ± 1.4 times/week at 1, 2, and 3 months after treatment, respectively (p < 0.001). After 3 months, 93.5% of children passed soft stools. Clinical symptoms such as anal pain, straining during defecation; stool-withholding posture, and bloody stools decreased markedly over time (p < 0.01). Treatment efficacy was achieved in 66.1% after 1 month, increasing to 85.5% and 93.5% after 2 and 3 months, respectively (p < 0.001). Adverse effects occurred at a low rate, were mild in severity, and did not affect treatment outcomes. Conclusion: The PEG 3350 regimen demonstrated high efficacy and safety in the management of functional constipation in children, significantly improving clinical symptoms and contributing to enhanced quality of life in pediatric patients.

Article Details

References

1. Tran DL, Sintusek P. Functional constipation in children: What physicians should know. World J Gastroenterol. 2023;29(8):1261-1288.
2. Tabbers MM, DiLorenzo C, Berger MY, et al. Evaluation and treatment of functional constipation in infants and children: Evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr. 2014; 58(2):258-274.
3. Drossman DA, Chang L, Chey WD, et al. Rome IV Diagnostic Criteria for Functional Gastrointestinal Disorders. Rome Foundation; 2016. Available at: https://theromefoundation. org/rome-iv/criteria/. Accessed 14/09/2025.
4. Hyams JS, Di Lorenzo C, Saps M, Shulman RJ, Staiano A, van Tilburg M. Functional Disorders: Children and Adolescents. Gastroenterology. 2016;150(6):1456-1468.
5. Trịnh Văn Long, Nguyễn Thị Việt Hà. Đánh giá hiệu quả của phác đồ sử dụng polyethylene glycol 3350 trong điều trị táo bón mạn tính ở trẻ em tại Bệnh viện Nhi Thanh Hóa. Tạp chí Y học Việt Nam. 2022;513(2):114-117.
6. Đào Thị Trân Huyền, Nguyễn Thị Việt Hà. Hiệu quả của hai phác đồ sử dụng polyethylene glycol 3350 và lactulose trong điều trị táo bón mạn tính chức năng ở trẻ em dưới 6 tuổi. Tạp chí Nghiên cứu Y học. 2021;145(9):119-128.
7. Nguyễn Thị Thơm, Nguyễn Thị Việt Hà. Hiệu quả của phác đồ sử dụng polyethylene glycol 3350 trong điều trị táo bón chức năng ở trẻ em tại Bệnh viện Sản Nhi Nghệ An. Tạp chí Y học Việt Nam. 2024;542(1):322-326.
8. Dheivamani N, Thomas W, Bannerjii R, Mukherjee M, Mitra M. Efficacy of polyethylene glycol 3350 as compared to lactulose in treatment of ROME IV criteria–defined pediatric functional constipation: A randomized controlled trial. Indian J Gastroenterol. 2021;40(2):227-233.